The ReoPro Retavase Reperfusion of Stroke Safety Study (ROSIE) is an NIH-sponsored Phase II trial evaluating intravenous reteplase in combination with abciximab for the treatment of patients with ...
Treatment Options: Saving Lives, Restoring Future The main goal for ischemic stroke’s treatment is to dissolve the clot blocking blood flow to the brain. The standard treatment is tPA ...
For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months ...
For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months ...
Dr Rahul OinamStroke is a neurological disease caused by sudden interruption of blood supply to a part of the brain causing loss of some function of the brain. The word stroke is derived from the noti ...